Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid

Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid

This study was performed to determine the efficacy of conversion therapy in intrahepatic cholangiocarcinoma (IHCC) and explore the feasibility of cancer organoid to direct the conversion therapy of IHCC. Patient data were retrospectively reviewed in this study and cancer organoids were established u...

Full description

Bibliographic Details
Main Authors: Zhiwei Wang, Yun Jin, Yinghao Guo, Zhenhua Tan, Xiaoxiao Zhang, Dan Ye, Yuanquan Yu, Shuyou Peng, Lei Zheng, Jiangtao Li
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
intrahepatic cholangiocarcinoma
conversion therapy
organoid
overall survival
genetic profiles
drug screening
Online Access:https://www.mdpi.com/2072-6694/13/5/1179

Internet

https://www.mdpi.com/2072-6694/13/5/1179

Similar Items